Amgen Highlights The Latest EVENITY™ (Romosozumab) And Prolia® (Denosumab) Research At The American Society For Bone And Mineral Research Annual Meeting

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 9/21/2026

1. SPY
2. WBD
3. NVDA
4. PSKY
5. TSLA
6. USO
7. AMD
8. META
9. AMC
10. ACN

Go back to Amgen Highlights The Latest EVENITY™ (Romosozumab) And Prolia® (Denosumab) Research At The American Society For Bone And Mineral Research Annual Meeting
Amgen Inc (NASDAQ: AMGN) Delayed: 392.77 +7.12 (1.85%)
Previous Close $385.65    52 Week High $176.85 
Open $385.71    52 Week Low $133.64 
Day High $394.50    P/E 59.15 
Day Low $381.90    EPS $6.64 
Volume 1,257,243